Neurocrine Bio Drug Licensed From Takeda Flunks Mid-Stage Test in Depression
An experimental depression drug that joined the Neurocrine Biosciences pipeline as part of a broader package from Takeda Pharmaceutical failed ...
Tag: Bio
Cartography Bio Corrals $67M to Bring Targeted Colorectal Cancer Drug Into the Clinic
Colorectal cancer patients whose disease exhibits certain rare genetic signatures have the option of treatment with immunotherapies. But these targeted ...
Startup Treeline Bio Emerges From the Shadows With $1B+ Raised and 3 Cancer Drugs in the Clinic
How can a biotech startup raise more than $1 billion over four plus years and say almost nothing publicly along ...
Dispatch Bio raises $216 million for solid tumor immunotherapy
Angus Chen covers all issues broadly related to cancer including drugs, policy, science, and equity. He joined STAT in 2021 ...
Seeing a Better Way for Eye Drug R&D, Character Bio Lands $93M for Two Trials in Dry AMD
A clinical trial is typically the first look at how an experimental drug works in humans. Character Biosciences is entering ...
Cash-Strapped Gene Therapy Firm Bluebird Bio Agrees to Acquisition by Private Equity
Bluebird Bio, a company that steered three gene therapies to FDA approval but struggled to commercialize them, has found the ...
Aiming to Outdo Rivals in Severe Asthma, Upstream Bio Upsizes IPO to $225M
Asthma patients have many drug options, but many patients find these choices either inconvenient or inadequate for severe cases of ...
Discover the latest in health and fitness with Your Health 247. Get expert advice, workout routines, healthy recipes, and mental wellness tips to lead a healthier, happier life. Stay informed and empowered with us!